Prevention of Post-colon ESD Coagulation Syndrome using Polysaccharide Hemostatic Powder

Prevention of Post-colon Endoscopic Submucosal Dissection Coagulation Syndrome using Polysaccharide Hemostatic Powder: a Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008728

Enrollment

196

Registered

2023-08-22

Start date

2023-10-25

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : For the colon lesions, after performing endoscopic submucosal dissection, the intervention group applied NexPowder, a polysaccharide powder hemostatic agent, to the artificial ulcer,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study targeted patients who visited to undergo endoscopic submucosal dissection of the colon for lesions larger than 20mm in size.

Exclusion criteria

Exclusion criteria: ? The size of the lesion is less than 2cm ? The lesion is a pedunculated polyp ?The lesion is removed by a different method than endoscopic submucosal dissection (ESD) (such as endoscopic mucosal resection) ? Perforation occurs during ESD or ESD is not completed ? The artificial ulcer created after ESD is completely closed with endoscopic clips ? The operator’s experience of ESD is less than 50 cases ? The patient does not agree to participate in the study

Design outcomes

Primary

Measure	Time frame
Occurrence of electrocoagulation syndrome after colonic submucosal dissection	—

Secondary

Measure	Time frame
Risk factors for electrocoagulation syndrome after colonic submucosal dissection	—

Countries

Korea, Republic of

Contacts

Public ContactYunho Jung

Soon Chun Hyang University Hospital Cheonan

yunho7575@gmail.com+82-41-570-3742

Outcome results